German International Classification of Disease (ICD)-10 delayed till 1998:
This article was originally published in Clinica
Full implementation of the German disease coding system for reimbursement will be delayed until January 1998 (see Clinica No 688, p 3). Both inpatient and outpatient procedures will have to conform to the coding, ICD-10, at the same time. This will avoid the problem of conflicting codings between in- and outpatient care, since hospitals may use ICD-9 only until the end of 1997. It is expected that ICD-10 will undergo revisions before its implementation including provisions for data confidentiality. A working group will prepare a review of the practical implications by the end of 1996. A pilot study will be undertaken in the first half of 1997.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.